NCT02379637

Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough

A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multiple-Dose, Proof-of-Concept Study to Evaluate the Efficacy of N-acetylcysteine Capsules in the Treatment of the Common Cold (Viral URTI) Associated With Cough in an Adult Population

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to improve knowledge regarding the initial effectiveness of N-acetylcysteine (NAC) on cold and cough symptoms.

Conditions

• Common Cold Associated With Cough

Interventions

Type	Name	Description
DRUG	N-acetylcysteine
DRUG	Placebo

Timeline

• Start date: 2015-01-01
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2015-03-05
• Last updated: 2016-07-11
• Results posted: 2016-07-11

Locations

5 sites across 1 country: Canada